Skip to main content

Saturday Morning Lectures Spring 2021
The Spring 2021 series presents a variety of topics, from rare isotopes to optics, nano-machines to black holes. Now in a virtual livestream format, the Saturday Morning Lecture series allows us to continue to deliver equal parts accessible and interesting science talks for the general public. Read more here.
TRIUMF 20-year Vision Development Plan
TRIUMF is preparing a 20-year Vision to project TRIUMF’s main activities for the period until ~2042, as well as the need for new facilities and infrastructure to service these activities. Read more here.
TRIUMF community rallies in response to COVID-19 pandemic
In the face of the global COVID-19 pandemic, groups from across the TRIUMF community have mobilized to support a variety of health-focused initiatives.
Thank you, TRIUMF!
As we continue to face the impact of the coronavirus on TRIUMF and the global science community, we want to take a moment to acknowledge the efforts of everyone at the lab doing their part each day.
New T2K results establish significant boundaries on neutrino oscillation
With results published recently in the prestigious journal Nature, T2K researchers, including several TRIUMF scientists, have have made an important first step in the comparison of neutrino and antineutrino oscillation.
TRIUMF welcomes Waterloo as newest member University
Waterloo becomes TRIUMF’s 21st member university. Welcome, Waterloo!
TRIUMF's Five-Year Plan 2020-2025
Our Five-Year Plan 2020-2025 lays out a vision for TRIUMF for the next five years and the decades beyond. It is designed to maximize our impact, build on our existing strengths, and capitalize on emerging opportunities. We invite you to explore our plan.
Prime Minister of Canada Announces Establishment of Premier Centre for Advanced Medical Isotope Research and Development at TRIUMF
Today, TRIUMF welcomed Prime Minister Trudeau for a special visit where he announced investments to support a new state-of-the art life sciences facility, the Institute for Advanced Medical Isotopes (IAMI).

Home

!

TRIUMF's latest Coronavirus (COVID-19) advisories and updates are available here [Revised: January 20, 2020]

Headlines & Research Highlights

Hunting with the BeEST: PRL paper establishes new boundaries in search for sterile neutrinos

20 January 2021

An international team that includes researchers from TRIUMF has published new measurements for the exclusion limits for sterile neutrinos.

New paper provides novel predictions for nuclear driplines up to iron

13 January 2021

A new paper published by TRIUMF Theory Department scientist Jason Holt and colleagues from the University of Washington and Germany has provided first-principles predictions of which isotopes can and can’t exist for elements from helium to iron.

New Order of Canada appointments recognize TRIUMF BOM community members

12 January 2021

On December 30th, 2020, Her Excellency the Right Honourable Julie Payette, Governor General of Canada announced 114 new appointments to the Order of Canada, including the recognition of two distinguished individuals from TRIUMF's Board of Management community.

Initial beam through CANREB brings first glimpse of new era of TRIUMF science

18 December 2020

TRIUMF scientists and engineers achieved a major milestone for the Advanced Rare Isotope Laboratory (ARIEL), maneuvering for the first time a radioactive isotope beam through ARIEL's CANREB facility and into the ISAC-II experimental hall.

Cyclotron-produced technetium-99m approved by Health Canada

17 December 2020

Health Canada has approved cyclotron-produced technetium-99m, greenlighting the made-in-Canada technology for national implementation and opening the door to a greener, more reliable way to make the most commonly used medical isotope.

TRIUMF strikes landmark isotope deal to expand access to actinium-225

16 December 2020

TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225, a valuable but scarce radioisotope with tremendous promise as a cancer treatment.

See all Stories

Universities